Jo Ledingham

Publications (3)12.71 Total impact

• Article: BSR and BHPR guidelines on the use of rituximab in rheumatoid arthritis.

  Marwan Bukhari, Rikki Abernethy, Chris Deighton, Tina Ding, Kimme Hyrich, Mark Lunt, Raashid Luqmani, Patrick Kiely, Ailsa Bosworth, Jo Ledingham, Andrew Ostör, Kate Gadsby, Frank McKenna, Diana Finney, Josh Dixey
  Rheumatology (Oxford, England) 05/2011; 50(12):2311-3. · 4.24 Impact Factor
• Source

  Available from: Kate Gadsby

  Article: BSR and BHPR rheumatoid arthritis guidelines on safety of anti-TNF therapies.

  Tina Ding, Jo Ledingham, Raashid Luqmani, Sarah Westlake, Kimme Hyrich, Mark Lunt, Patrick Kiely, Marwan Bukhari, Rikki Abernethy, Ailsa Bosworth, Andrew Ostor, Kate Gadsby, Frank McKenna, Diana Finney, Josh Dixey, Chris Deighton
  Rheumatology (Oxford, England) 11/2010; 49(11):2217-9. · 4.24 Impact Factor
• Source

  Available from: Marwan Bukhari

  Article: BSR and BHPR rheumatoid arthritis guidelines on eligibility criteria for the first biological therapy.

  Chris Deighton, Kimme Hyrich, Tina Ding, Jo Ledingham, Mark Lunt, Raashid Luqmani, Patrick Kiely, Marwan Bukhari, Rikki Abernethy, Andrew Ostor, Ailsa Bosworth, Kate Gadsby, Frank McKenna, Diana Finney, Josh Dixey
  Rheumatology (Oxford, England) 03/2010; 49(6):1197-9. · 4.24 Impact Factor